View in EDS

Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27.

Saved in:
Bibliographic Details
Title: Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27.
Authors: Goh M; Program on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, 1620 Tremont, Suite 3030, Boston, MA, 02120, United States.; Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States., McEnany M; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, 12850 East Montview Boulevard, Aurora, CO, 80045, USA., Freeman R; IQVIA, 37 North Wharf Road, London, W2 1AF, United Kingdom., Newton M; IQVIA, Kirschgartenstrasse 14, 4051, Basel, Switzerland., Kesselheim AS; Program on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, 1620 Tremont, Suite 3030, Boston, MA, 02120, United States., Outterson K; Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States.
Source: EClinicalMedicine [EClinicalMedicine] 2025 Sep 08; Vol. 88, pp. 103485. Date of Electronic Publication: 2025 Sep 08 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2025.103485